SaltielEWardA. Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in platelet-dependent disease states. Drugs1987;34: 222–62.
2.
NobleSGoaKL. Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke. Drugs & Aging1996;8: 214–32.
3.
HassWKEastonJDAdamsHPPrise-PhilipsWMolonyBAAndersonSA randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med1989;321:501–7.
4.
GentMBlakelyJAEastonJDEllisDJHachinskyVCHarbisonJWThe Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet1989;1:1215–20.
5.
van ZantenSJO VeldhuyzenMcCormickCW. Antinuclear antibody-positive ticlopidine-induced hepatitis. Can J Gastroenterol1996;10: 231–2.
